Natural Alternative Sweeteners and Diabetes Management

Current Diabetes Reports

Volumn 19, Issue 12, 2019, Pages

  Mejia, Emily ^a   Pearlman, Michelle ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI HEALTH SYSTEM   (United States)

Author keywords

Diabetes; Natural alternative sweeteners; Rare sugars; Stevia; Sugar alcohols

Indexed keywords

ALLOSE; ANTIOXIDANT; PLANT EXTRACT; PSICOSE; SCHISANDRA CHINENSIS EXTRACT; SORBOSE; STEVIA REBAUDIANA EXTRACT; SUGAR ALCOHOL; SWEETENING AGENT; TAGATOSE; UNCLASSIFIED DRUG; CARBOHYDRATE; GLUCOSE; PLANT MEDICINAL PRODUCT;

ANTIOXIDANT ACTIVITY; BODY WEIGHT; DIABETES MELLITUS; DIET THERAPY; DISEASE ASSOCIATION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PREVALENCE; REVIEW; SIRAITIA GROSVENORII; SPRAGUE DAWLEY RAT; STEVIA REBAUDIANA; WISTAR RAT; ANIMAL; HOMEOSTASIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; STEVIA;

ANIMALS; DIABETES MELLITUS; GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; OBESITY; PLANT PREPARATIONS; STEVIA; SUGAR ALCOHOLS; SUGARS; SWEETENING AGENTS;

EID: 85075476471     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-019-1273-8     Document Type: Review

References (41)

1. Toews I, Kuellenberg de Gaudry D, Sommer H, Meerpohl JJ, Lohner S. Non-nutritive sweeteners for diabetes mellitus. The Cochrane Database of Systematic Reviews. 2017;2017(11):CD012885. 10.1002/14651858.CD012885.
2. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999;48(1):1–9. 10.2337/diabetes.48.1.1.
3. Prata C, Zambonin L, Rizzo B, Maraldi T, Angeloni C, Vieceli Dalla Sega F, et al. Glycosides from Stevia rebaudiana bertoni possess insulin-mimetic and antioxidant activities in rat cardiac fibroblasts. Oxid Med Cell Longev. 2017;2017:3724545. 10.1155/2017/3724545.
4. Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes care. 2014;37(Supplement 1):S120–S43.
5. Adult obesity facts. Center for Disease Control and Prevention. 2018. https://www.cdc.gov/obesity/data/adult.html. Accessed 6/23/19.
6. Organization WH. Global report on diabetes. 2016. 2017.
7. Bender C, Graziano S, Zimmermann BF. Study of Stevia rebaudiana Bertoni antioxidant activities and cellular properties. Int J Food Sci Nutr. 2015;66(5):553–8.
8. Carrera-Lanestosa A, Moguel-Ordonez Y, Segura-Campos M. Stevia rebaudiana Bertoni: a natural alternative for treating diseases associated with metabolic syndrome. J Med Food. 2017;20(10):933–43. 10.1089/jmf.2016.0171.
9. Tey SL, Salleh NB, Henry CJ, Forde CG. Effects of non-nutritive (artificial vs natural) sweeteners on 24-h glucose profiles. Eur J Clin Nutr. 2017;71(9):1129–32. 10.1038/ejcn.2017.37.
10. Tey S, Salleh N, Henry J, Forde C. Effects of aspartame-, monk fruit-, stevia-and sucrose-sweetened beverages on postprandial glucose, insulin and energy intake. Int J Obes. 2017;41(3):450.
11. Ritu M, Nandini J. Nutritional composition of Stevia rebaudiana, a sweet herb, and its hypoglycaemic and hypolipidaemic effect on patients with non-insulin dependent diabetes mellitus. J Sci Food Agric. 2016;96(12):4231–4.
12. Onakpoya IJ, Heneghan CJ. Effect of the natural sweetener, steviol glycoside, on cardiovascular risk factors: a systematic review and meta-analysis of randomised clinical trials. Eur J Prev Cardiol. 2015;22(12):1575–87.
13. Ahmad U, Ahmad RS. Anti diabetic property of aqueous extract of Stevia rebaudiana bertoni leaves in streptozotocin-induced diabetes in albino rats. BMC Complement Altern Med. 2018;18(1):179–11. 10.1186/s12906-018-2245-2.
14. Elnaga NA, Massoud MI, Yousef M, Mohamed HH. Effect of stevia sweetener consumption as non-caloric sweetening on body weight gain and biochemical’s parameters in overweight female rats. Annals of Agricultural Sciences. 2016;61(1):155–63.
15. Assaei R, Mokarram P, Dastghaib S, Darbandi S, Darbandi M, Zal F, et al. Hypoglycemic effect of aquatic extract of Stevia in pancreas of diabetic rats: PPARγ-dependent regulation or antioxidant potential. Avicenna journal of medical biotechnology. 2016;8(2):65.
16. Aranda-González I, Moguel-Ordóñez Y, Chel-Guerrero L, Segura-Campos M, Betancur-Ancona D. Evaluation of the antihyperglycemic effect of minor steviol glycosides in normoglycemic and induced-diabetic Wistar rats. J Med Food. 2016;19(9):844–52. 10.1089/jmf.2016.0014.
17. • Akbarzadeh S, Eskandari F, Tangestani H, Bagherinejad ST, Bargahi A, Bazzi P et al. The effect of Stevia rebaudiana on serum omentin and visfatin level in STZ-induced diabetic rats. Journal of dietary supplements. 2015;12(1):11-22. Proposed molecular mechanism for stevia’s insulin-mimetic properties.
18. Mooradian AD, Smith M, Tokuda M. The role of artificial and natural sweeteners in reducing the consumption of table sugar: a narrative review. Clinical nutrition eSPen. 2017;18:1–8.
19. Noronha JC, Braunstein CR, Glenn AJ, Khan TA, Viguiliouk E, Noseworthy R, et al. The effect of small doses of fructose and allulose on postprandial glucose metabolism in type 2 diabetes: a double-blind, randomized, controlled, acute feeding, equivalence trial. Diabetes Obes Metab. 2018;20(10):2361–70. 10.1111/dom.13374.
20. Han Y, Kwon E-Y, Yu M, Lee S, Kim H-J, Kim S-B, et al. A preliminary study for evaluating the dose-dependent effect of d-allulose for fat mass reduction in adult humans: a randomized, double-blind. Placebo-Controlled Trial Nutrients. 2018;10(2):160. 10.3390/nu10020160.
21. Hayashi N, Yamada T, Takamine S, Iida T, Okuma K, Tokuda M. Weight reducing effect and safety evaluation of rare sugar syrup by a randomized double-blind, parallel-group study in human. J Funct Foods. 2014;11:152–9. 10.1016/j.jff.2014.09.020.
22. • Ensor M, Williams J, Smith R, Banfield A, Lodder RA. Effects of three low-doses of D-tagatose on glycemic control over six months in subjects with mild type 2 diabetes mellitus under control with diet and exercise. Journal of endocrinology, diabetes & obesity. 2014;2(4):1057. Identifies minimum dosage required to see positive effects on blood glucose after six months of treatment.
23. •• Ensor M, Banfield AB, Smith RR, Williams J, Lodder RA. Safety and efficacy of D-tagatose in glycemic control in subjects with type 2 diabetes. Journal of endocrinology, diabetes & obesity. 2015;3(1). Results were reproducible with a longer treatment period with a larger and more diverse participant population.
24. Nagata Y, Mizuta N, Kanasaki A, Tanaka K. Rare sugars, d -allulose, d -tagatose and d -sorbose, differently modulate lipid metabolism in rats. J Sci Food Agric. 2018;98(5):2020–6. 10.1002/jsfa.8687.
25. • Shintani T, Yamada T, Hayashi N, Iida T, Nagata Y, Ozaki N et al. Rare sugar syrup containing D-allulose but not high-fructose corn syrup maintains glucose tolerance and insulin sensitivity partly via hepatic glucokinase translocation in Wistar rats. Journal of agricultural and food chemistry. 2017;65(13):2888-94. Evaluates the mechanism of action of rare sugars and suggests that RSS affects glucose metabolism through GK and increased glycogen levels.
26. Iwasaki Y, Sendo M, Dezaki K, Hira T, Sato T, Nakata M, et al. GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose. Nature Communications. 2018;9(1). 10.1038/s41467-017-02488-y.
27. Ochiai M, Misaki K, Yamada T, Iida T, Okuma K, Matsuo T. Comparison of anti-obesity effect between two types of syrup containing rare sugars in Wistar rats. J Nutr Sci Vitaminol. 2017;63(3):208–13. 10.3177/jnsv.63.208.
28. • Nagata Y, Kanasaki A, Tamaru S, Tanaka K. D-psicose, an epimer of D-fructose, favorably alters lipid metabolism in Sprague–Dawley rats. Journal of agricultural and food chemistry. 2015;63(12):3168–76. First study to show that allulose may modulate lipid absorption in the small intestine, explaining its hypolipidemic actions.
29. • Hossain A, Yamaguchi F, Hirose K, Matsunaga T, Sui L, Hirata Y et al. Rare sugar D-psicose prevents progression and development of diabetes in T2DM model Otsuka Long-Evans Tokushima Fatty rats. Drug Design, Development and Therapy. 2015:525. doi:10.2147/dddt.s71289. Long term (greater than 1 year) provides evidence supporting rare sugars’ role in decreasing inflammation.
30. Yamada T, Hayashi N, Iida T, Takamine S, Okuma K, Matsuo T. Dietary D-sorbose decreases serum insulin levels in growing Sprague-Dawley rats 2014;60(4):297–9. doi:10.3177/jnsv.60.297.
31. Gray A. Nutritional recommendations for individuals with diabetes. Endotext [Internet]. MDText. com, Inc.; 2015.
32. Jain T, Grover K. Sweeteners in human nutrition. International Journal of Health Sciences and Research. 2015;5(5):439–51.
33. Wölnerhanssen BK, Cajacob L, Keller N, Doody A, Rehfeld JF, Drewe J, et al. Gut hormone secretion, gastric emptying, and glycemic responses to erythritol and xylitol in lean and obese subjects. American Journal of Physiology-Endocrinology and Metabolism. 2016;310(11):E1053–E61. 10.1152/ajpendo.00037.2016.
34. Overduin J, Collet T-H, Medic N, Henning E, Keogh JM, Forsyth F, et al. Failure of sucrose replacement with the non-nutritive sweetener erythritol to alter GLP-1 or PYY release or test meal size in lean or obese people. Appetite. 2016;107:596–603. 10.1016/j.appet.2016.09.009.
35. Mohsenpour MA, Kaseb F, Nazemian R, Mozaffari-Khosravi H, Fallahzadeh H, Salehi-Abargouei A. The effect of a new mixture of sugar and sugar-alcohols compared to sucrose and glucose on blood glucose increase and the possible adverse reactions: a phase I double-blind, three-way randomized cross-over clinical trial. Endocrinologia, diabetes y nutricion. 2019.
36. Wen H, Tang B, Stewart AJ, Tao Y, Shao Y, Cui Y, et al. Erythritol attenuates postprandial blood glucose by inhibiting α-glucosidase. J Agric Food Chem. 2018;66(6):1401–7. 10.1021/acs.jafc.7b05033.
37. Chukwuma CI, Islam S. Xylitol improves anti-oxidative defense system in serum, liver, heart, kidney and pancreas of normal and type 2 diabetes model of rats. Acta Pol Pharm. 2017;74(3):817–26.
38. Rahman MA, Islam MS. Xylitol improves pancreatic islets morphology to ameliorate type 2 diabetes in rats: a dose response study. J Food Sci. 2014;79(7):H1436–42. 10.1111/1750-3841.12520.
39. Lee YJ, Jeong J, Kim MO, Nam J-O. The positive effect of luohanguo as sugar substitute on blood glucose and metabolism in streptozotocin-induced diabetic mice. Applied Microscopy. 2016;46(3):140–9.
40. Gangoso A, Robben DM, Wesley MC, Rodriguez PRR, editors. Comparison of the glycemic response of white sugar and monk fruit sweetener among normoglycemic subjects. 7th International Scholars Conference Proceeding; 2018.
41. Liu H, Qi X, Yu K, Lu A, Lin K, Zhu J, et al. AMPK activation is involved in hypoglycemic and hypolipidemic activities of mogroside-rich extract from Siraitia grosvenorii (Swingle) fruits on high-fat diet/streptozotocin-induced diabetic mice. Food Funct. 2019. 10.1039/c8fo01486h.